Jay A. Baker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jay A. Baker has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Joseph Y. Lo
Duke University
5 shared publications Eric L. Rosen
2 shared publications- Carey E. Floyd
Department of Biomedical Engineering and Department of Radiology, Duke Advanced Imaging Laboratories Box 2623DUMC, Duke University, Durham, NC 27710, USA
1 shared publication - Connie Kim
Department of Radiology Duke University School of Medicine Durham North Carolina USA
1 shared publication David M. Delong
1 shared publicationEdgardo I. Gimenez
1 shared publication
Latest Publications
- 30 July 2024
- Published by Oxford University Press (OUP) in Journal of Breast Imaging
- Vol. 6 (4) , 337
2023–2024 Editor’s Recognition Awards
Many people have a hand in the success of the Journal of Breast Imaging (JBI), including our Associate Editors and Editorial Board who collectively determine the direction and standards of the journal. An often unrecognized and unsung group that is equally responsible for the success of JBI are those who peer review submitted manuscripts. This uncompensated work is performed by those most dedicated to the advancement of the field of breast imaging in order to improve patient care and outcomes. The entire editorial team at JBI would like to offer our sincere thanks and appreciation to all who have reviewed papers during the period April 1, 2023 through March 31, 2024. We would like to offer particular thanks to the 19 Exceptional Reviewers who each completed at least 5 reviews with near perfect scores for timeliness and depth of review, along with 22 Distinguished Reviewers who each completed at least 3 timely and relevant reviews. Thank you.
- 30 July 2024
- Published by Oxford University Press (OUP) in Journal of Breast Imaging
- Vol. 6 (4) , 337
2023–2024 Editor’s Recognition Awards
Many people have a hand in the success of the Journal of Breast Imaging (JBI), including our Associate Editors and Editorial Board who collectively determine the direction and standards of the journal. An often unrecognized and unsung group that is equally responsible for the success of JBI are those who peer review submitted manuscripts. This uncompensated work is performed by those most dedicated to the advancement of the field of breast imaging in order to improve patient care and outcomes. The entire editorial team at JBI would like to offer our sincere thanks and appreciation to all who have reviewed papers during the period April 1, 2023 through March 31, 2024. We would like to offer particular thanks to the 19 Exceptional Reviewers who each completed at least 5 reviews with near perfect scores for timeliness and depth of review, along with 22 Distinguished Reviewers who each completed at least 3 timely and relevant reviews. Thank you.
- 30 July 2024
- Published by Oxford University Press (OUP) in Journal of Breast Imaging
- Vol. 6 (4) , 335-336
Lessons Learned
It is my honor and pleasure to introduce myself as the interim Editor-in-Chief for the Journal of Breast Imaging (JBI). By the time you read this, the Society of Breast Imaging will have likely completed its search for the next long-term Editor. I have learned much in the few months I have had the opportunity to fill this role. First, I learned the journal owes Dr Wendy DeMartini, the previous Editor, a tremendous debt of gratitude. In her tenure as Editor, Dr DeMartini guided JBI through an important maturing phase as the journal settled into its place as a leading source for information related to all aspects of the science and practice of breast imaging. Significantly, along with Kathleen Gaffney, an expert consultant in journal operations, Dr DeMartini successfully guided JBI to inclusion in PubMed indexing, an essential milestone for a successful journal that makes the contents of JBI searchable by researchers everywhere.
- 30 July 2024
- Published by Oxford University Press (OUP) in Journal of Breast Imaging
- Vol. 6 (4) , 335-336
Lessons Learned
It is my honor and pleasure to introduce myself as the interim Editor-in-Chief for the Journal of Breast Imaging (JBI). By the time you read this, the Society of Breast Imaging will have likely completed its search for the next long-term Editor. I have learned much in the few months I have had the opportunity to fill this role. First, I learned the journal owes Dr Wendy DeMartini, the previous Editor, a tremendous debt of gratitude. In her tenure as Editor, Dr DeMartini guided JBI through an important maturing phase as the journal settled into its place as a leading source for information related to all aspects of the science and practice of breast imaging. Significantly, along with Kathleen Gaffney, an expert consultant in journal operations, Dr DeMartini successfully guided JBI to inclusion in PubMed indexing, an essential milestone for a successful journal that makes the contents of JBI searchable by researchers everywhere.
- 6 July 2021
- Published by Oxford University Press (OUP) in Journal of Breast Imaging
- Vol. 3 (4) , 405-406
Location, Location, Location
- 6 July 2021
- Published by Oxford University Press (OUP) in Journal of Breast Imaging
- Vol. 3 (4) , 405-406
Location, Location, Location
- 1 September 2019
- Published by Elsevier in Clinical Imaging
- Vol. 57, 45-49
MRI predictors of tumor-positive margins after breast-conserving surgery
- 1 September 2019
- Published by Elsevier in Clinical Imaging
- Vol. 57, 45-49
MRI predictors of tumor-positive margins after breast-conserving surgery
- 18 August 2019
- Published by Oxford University Press (OUP) in Journal of Breast Imaging
- Vol. 1 (3) , 186-191
A Proposal to Define Three New Breast Calcification Shapes: Square, Sandwich, and Teardrop, Pill & Capsule
Objective: To define and illustrate three new descriptors for microcalcification morphology on mammography, and provide a preliminary assessment of their potential clinical value. Methods: The institutional review board approved this retrospective study and waived the requirement for informed consent. One thousand consecutive biopsy-proven cases of microcalcifications were retrospectively reviewed by the index study observer, a fellowship-trained breast radiologist blinded to histologic outcome. Each case was evaluated for traditional Breast Imaging Reporting and Data System (BI-RADS) morphology descriptors, as well as for the presence of one of three proposed new calcification morphology descriptors: (1) square, (2) sandwich, and (3) teardrop, pill & capsule. Positive predictive value (PPV) for each proposed shape was calculated. Interobserver variability was calculated on a subset of 200 cases, which were evaluated by two additional breast radiologists blinded to the interpretation of the index observer. Results: Of 1000 cases, 702 (70.2%) were benign, and 298 (29.8%) were malignant. There were 51 (5.1%) square and 60 (6.0%) sandwich calcification cases, which were all benign at biopsy (PPV, 0%). Of the 106 (10.6%) cases that included teardrop, pill & capsule calcifications, 90 were malignant (PPV, 84.9%). Interobserver variability for the traditional BI-RADS morphology descriptors (κ = 0.40) was comparable to observer variability of the proposed new morphologies: square (κ = 0.39), sandwich (κ = 0.47), and teardrop, pill & capsule (κ = 0.49). Conclusion: The proposed calcification descriptors square and sandwich-shaped had a PPV of 0%, and they may represent new typically benign morphologies. In contrast, teardrop, pill & capsule–shaped calcifications indicate a higher likelihood of malignancy than that of previously established descriptors.
- 18 August 2019
- Published by Oxford University Press (OUP) in Journal of Breast Imaging
- Vol. 1 (3) , 186-191
A Proposal to Define Three New Breast Calcification Shapes: Square, Sandwich, and Teardrop, Pill & Capsule
Objective: To define and illustrate three new descriptors for microcalcification morphology on mammography, and provide a preliminary assessment of their potential clinical value. Methods: The institutional review board approved this retrospective study and waived the requirement for informed consent. One thousand consecutive biopsy-proven cases of microcalcifications were retrospectively reviewed by the index study observer, a fellowship-trained breast radiologist blinded to histologic outcome. Each case was evaluated for traditional Breast Imaging Reporting and Data System (BI-RADS) morphology descriptors, as well as for the presence of one of three proposed new calcification morphology descriptors: (1) square, (2) sandwich, and (3) teardrop, pill & capsule. Positive predictive value (PPV) for each proposed shape was calculated. Interobserver variability was calculated on a subset of 200 cases, which were evaluated by two additional breast radiologists blinded to the interpretation of the index observer. Results: Of 1000 cases, 702 (70.2%) were benign, and 298 (29.8%) were malignant. There were 51 (5.1%) square and 60 (6.0%) sandwich calcification cases, which were all benign at biopsy (PPV, 0%). Of the 106 (10.6%) cases that included teardrop, pill & capsule calcifications, 90 were malignant (PPV, 84.9%). Interobserver variability for the traditional BI-RADS morphology descriptors (κ = 0.40) was comparable to observer variability of the proposed new morphologies: square (κ = 0.39), sandwich (κ = 0.47), and teardrop, pill & capsule (κ = 0.49). Conclusion: The proposed calcification descriptors square and sandwich-shaped had a PPV of 0%, and they may represent new typically benign morphologies. In contrast, teardrop, pill & capsule–shaped calcifications indicate a higher likelihood of malignancy than that of previously established descriptors.
- 1 July 2018
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 211 (1) , W80
Accurate Inputs for Costs and Benefits of Screening Mammography
- 1 July 2018
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 211 (1) , W80
Accurate Inputs for Costs and Benefits of Screening Mammography
- 1 February 2018
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 178 (2) , 298-299
False Information About Breast Cancer Screening
To the Editor Together, the recent Research Letter by Radhakrishnan and colleagues1 and the accompanying Editorial by Grady and Redberg,2 both published in a recent issue of JAMA Internal Medicine, provide strong evidence that primary care physicians recognize the value of screening mammography to improve the lives of their patients. The survey by Radhakrishnan and colleagues1 reports that most primary care physicians reject the US Preventive Services Task Force (USPSTF) contentious recommendations on screening. Rather, by recommending annual screening for their patients beginning at age 40 years, physicians surveyed in the fields of internal medicine, family medicine, and obstetrics and gynecology demonstrate that their understanding that all major medical organizations that comment on screening—the American Cancer Society (ACS), the American College of Radiology, the Society of Breast Imaging, the American Congress of Obstetricians and Gynecologists, and even the USPSTF itself—all agree that mortality is minimized by beginning annual screening at age 40 years, even though the USPSTF recommends screening begin at 50 years.
- 1 February 2018
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 178 (2) , 298-299
False Information About Breast Cancer Screening
To the Editor Together, the recent Research Letter by Radhakrishnan and colleagues1 and the accompanying Editorial by Grady and Redberg,2 both published in a recent issue of JAMA Internal Medicine, provide strong evidence that primary care physicians recognize the value of screening mammography to improve the lives of their patients. The survey by Radhakrishnan and colleagues1 reports that most primary care physicians reject the US Preventive Services Task Force (USPSTF) contentious recommendations on screening. Rather, by recommending annual screening for their patients beginning at age 40 years, physicians surveyed in the fields of internal medicine, family medicine, and obstetrics and gynecology demonstrate that their understanding that all major medical organizations that comment on screening—the American Cancer Society (ACS), the American College of Radiology, the Society of Breast Imaging, the American Congress of Obstetricians and Gynecologists, and even the USPSTF itself—all agree that mortality is minimized by beginning annual screening at age 40 years, even though the USPSTF recommends screening begin at 50 years.
- 1 June 2012
- Published by Elsevier in Academic Radiology
- Vol. 19 (6) , 667-674
Suspicious Breast Lesions Detected at 3.0 T Magnetic Resonance Imaging
- 1 June 2012
- Published by Elsevier in Academic Radiology
- Vol. 19 (6) , 667-674
Suspicious Breast Lesions Detected at 3.0 T Magnetic Resonance Imaging
- 1 October 2011
- Published by Elsevier in Academic Radiology
- Vol. 18 (10) , 1298-1310
Breast Tomosynthesis
- 1 October 2011
- Published by Elsevier in Academic Radiology
- Vol. 18 (10) , 1298-1310
Breast Tomosynthesis
- Open Access
- 18 March 2011
- Published by Wiley in Medical Physics
- Vol. 38 (4) , 1972-1980
Comparative performance of multiview stereoscopic and mammographic display modalities for breast lesion detection
PURPOSE: Mammography is known to be one of the most difficult radiographic exams to interpret. Mammography has important limitations, including the superposition of normal tissue that can obscure a mass, chance alignment of normal tissue to mimic a true lesion and the inability to derive volumetric information. It has been shown that stereomammography can overcome these deficiencies by showing that layers of normal tissue lay at different depths. If standard stereomammography (i.e., a single stereoscopic pair consisting of two projection images) can significantly improve lesion detection, how will multiview stereoscopy (MVS), where many projection images are used, compare to mammography? The aim of this study was to assess the relative performance of MVS compared to mammography for breast mass detection. METHODS: The MVS image sets consisted of the 25 raw projection images acquired over an arc of approximately 45 degrees using a Siemens prototype breast tomosynthesis system. The mammograms were acquired using a commercial Siemens FFDM system. The raw data were taken from both of these systems for 27 cases and realistic simulated mass lesions were added to duplicates of the 27 images at the same local contrast. The images with lesions (27 mammography and 27 MVS) and the images without lesions (27 mammography and 27 MVS) were then postprocessed to provide comparable and representative image appearance across the two modalities. All 108 image sets were shown to five full-time breast imaging radiologists in random order on a state-of-the-art stereoscopic display. The observers were asked to give a confidence rating for each image (0 for lesion definitely not present, 100 for lesion definitely present). The ratings were then compiled and processed using ROC and variance analysis. RESULTS: The mean AUC for the five observers was 0.614 +/- 0.055 for mammography and 0.778 +/- 0.052 for multiview stereoscopy. The difference of 0.164 +/- 0.065 was statistically significant with a p-value of 0.0148. CONCLUSIONS: The differences in the AUCs and the p-value suggest that multiview stereoscopy has a statistically significant advantage over mammography in the detection of simulated breast masses. This highlights the dominance of anatomical noise compared to quantum noise for breast mass detection. It also shows that significant lesion detection can be achieved with MVS without any of the artifacts associated with tomosynthesis.Thesi
- 18 March 2011
- Published by Wiley in Medical Physics
- Vol. 38 (4) , 1972-1980
Open AccessComparative performance of multiview stereoscopic and mammographic display modalities for breast lesion detection
PURPOSE: Mammography is known to be one of the most difficult radiographic exams to interpret. Mammography has important limitations, including the superposition of normal tissue that can obscure a mass, chance alignment of normal tissue to mimic a true lesion and the inability to derive volumetric information. It has been shown that stereomammography can overcome these deficiencies by showing that layers of normal tissue lay at different depths. If standard stereomammography (i.e., a single stereoscopic pair consisting of two projection images) can significantly improve lesion detection, how will multiview stereoscopy (MVS), where many projection images are used, compare to mammography? The aim of this study was to assess the relative performance of MVS compared to mammography for breast mass detection. METHODS: The MVS image sets consisted of the 25 raw projection images acquired over an arc of approximately 45 degrees using a Siemens prototype breast tomosynthesis system. The mammograms were acquired using a commercial Siemens FFDM system. The raw data were taken from both of these systems for 27 cases and realistic simulated mass lesions were added to duplicates of the 27 images at the same local contrast. The images with lesions (27 mammography and 27 MVS) and the images without lesions (27 mammography and 27 MVS) were then postprocessed to provide comparable and representative image appearance across the two modalities. All 108 image sets were shown to five full-time breast imaging radiologists in random order on a state-of-the-art stereoscopic display. The observers were asked to give a confidence rating for each image (0 for lesion definitely not present, 100 for lesion definitely present). The ratings were then compiled and processed using ROC and variance analysis. RESULTS: The mean AUC for the five observers was 0.614 +/- 0.055 for mammography and 0.778 +/- 0.052 for multiview stereoscopy. The difference of 0.164 +/- 0.065 was statistically significant with a p-value of 0.0148. CONCLUSIONS: The differences in the AUCs and the p-value suggest that multiview stereoscopy has a statistically significant advantage over mammography in the detection of simulated breast masses. This highlights the dominance of anatomical noise compared to quantum noise for breast mass detection. It also shows that significant lesion detection can be achieved with MVS without any of the artifacts associated with tomosynthesis.Thesi